Back to top

Image: Bigstock

Editas Medicine (EDIT) in Focus: Stock Moves 7.8% Higher

Read MoreHide Full Article

Editas Medicine, Inc. (EDIT - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $20.30 to $22.99 in the past one-month time frame.

The company has seen three positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Editas Medicine. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Editas Medicine currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. 

Editas Medicine, Inc. Price

Investors interested in the Medical – Biomedical and Genetics industry may consider Alkermes plc (ALKS - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is EDIT going up? Or down? Predict to see what others think:Up or Down

More Stock News: This Is Bigger than the iPhone!
 
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
 
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
 
Click here for the 6 trades >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Editas Medicine, Inc. (EDIT) - free report >>

Alkermes plc (ALKS) - free report >>